4-tert-Butyl-3',5'-dimethoxybenzophenone, 97.0%, 1g

2-(9,9-Dimethyl-9H-fluoren-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 99%, 1g

METHYL 9H-PYRROLO[2,3-B:5,4-C']DIPYRIDINE-6-CARBOXYLATE, 95.0%, 100mg

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethoxy)benzaldehyde, 98%, 100mg

(E)-2-(1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)acetonitrile, 97%, 5g

(2E)-3-[4-(benzyloxy)phenyl]-1-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

3-Chloro-2,6-difluorobenzylamine, 95.0%, 5g

Ethyl 3-hydroxyhexanoate, 95.0%, 100g

(S)-2,2'-Dimethoxy-1,1'-binaphthalene, ��97.0%, 25g

monoclonal de ratón anti-queratina K19, Ks19.2 (Z105.6), 0,2 ml

N-(4-Bromo-2-nitrophenyl)acetamide, 95.0%, 1g

4-Bromo-5-chlorothiophene-2-carboxylic acid, 96%, 50mg

3-fluoro-6-methylimidazo[1,2-a]pyridine-2-carboxylic acid hydrochloride, 95.0%, 250mg